MTOR and central nervous system cancer: Moreover, SLC7A11 was reported to be related to PI3K/AKT/mTOR signaling pathway in cancers, such as gastric cancer (17), glioma (18), pancreatic carcinoma (19), neuroendocrine tumors (20), but the interaction has not been clarified in breast cancer.